MARKET

PCVX

PCVX

Vaxcyte, Inc.
NASDAQ
74.37
+1.35
+1.85%
Pre Market: 74.37 0 0.00% 08:00 03/17 EDT
OPEN
73.91
PREV CLOSE
73.02
HIGH
75.04
LOW
72.89
VOLUME
25
TURNOVER
0
52 WEEK HIGH
121.06
52 WEEK LOW
58.10
MARKET CAP
9.58B
P/E (TTM)
-19.5566
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PCVX last week (0310-0314)?
Weekly Report · 3h ago
Fidelity Small Cap Index Fund Q4 2024 Review
Seeking Alpha · 3d ago
Vaxcyte Price Target Maintained With a $160.00/Share by Guggenheim
Dow Jones · 4d ago
Invesco Small Cap Growth Fund Q4 2024 Commentary
Seeking Alpha · 4d ago
Guggenheim Reiterates Buy on Vaxcyte, Maintains $160 Price Target
Benzinga · 4d ago
ClearBridge SMID Cap Growth Strategy Q4 2024 Commentary
Seeking Alpha · 6d ago
Weekly Report: what happened at PCVX last week (0303-0307)?
Weekly Report · 03/10 09:21
TD Cowen Sticks to Its Buy Rating for Vaxcyte (PCVX)
TipRanks · 03/07 13:39
More
About PCVX
Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). VAX-31, the Company’s next generation 31-valent PCV is developed for the prevention of IPD in adults. Its pipeline also includes VAX-A1, VAX-PG, and VAX-GI. VAX-A1, a novel conjugate vaccine candidate designed to prevent disease caused by Group A Streptococcus (Group A Strep). VAX-PG, a novel protein vaccine candidate targeting pathogen responsible for periodontitis, a chronic oral inflammatory disease. VAX-GI, a novel preclinical vaccine candidate being developed as a preventative treatment for dysentery and shigellosis. Its technology platform includes advanced chemistry and the XpressCF cell-free protein synthesis platform.

Webull offers Vaxcyte Inc stock information, including NASDAQ: PCVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCVX stock methods without spending real money on the virtual paper trading platform.